The Impact of a Visualized Steerable Sheath on Radiofrequency Catheter Ablation for First‐Time Atrial Fibrillation Ablation: A Prospective, Randomized, Single‐Blind Study
Catheterization and Cardiovascular Interventions · 2026
DOI: 10.1002/ccd.70716 ↗At a glance
Randomisierte kontrollierte Studie in Catheterization and Cardiovascular Interventions, 2026. Written by Chun-Kai Chen and 4 co-authors. Institution: Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei…. Major MEDLINE topics: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins, Cardiac Catheters. 18 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Johnson & Johnson, Johnson and Johnson.
Abstract (original language)
Background
A 3D electroanatomical mapping (3D‐EAM) visualized steerable sheath was designed to improve catheter placement and reduce radiation exposure during ablation, an established treatment for atrial fibrillation (AF). However, prospective randomized data comparing the procedural and clinical outcomes of visualized and non‐visualized steerable sheaths are limited.
Aims
To compare the impact of 3D‐EAM visualized and nonvisualized steerable sheaths on procedural and clinical outcomes in patients undergoing AF ablation.
Methods
This prospective randomized study included 100 patients who underwent radiofrequency catheter ablation for AF. Patients were randomized (1:1) to either a 3D‐EAM‐visualized steerable sheath (Vizigo) or a conventional non‐visualized steerable sheath (Agilis) group. Key endpoints included procedure and fluoroscopy times, pulmonary vein isolation (PVI) effectiveness, and 12‐month AF recurrence.
Results
Acute PVI was successfully achieved in all patients. Fluoroscopy time was significantly lower in the Vizigo group than that in the Agilis group (11.43 vs. 15.37 min, p = 0.0013), with a zero‐fluoroscopy workflow achievable post‐transseptal puncture. First‐pass PVI success in left‐sided veins was significantly higher in the Vizigo group than that in the Agilis group (84% vs. 64%, p = 0.023). At the 12‐month follow‐up, AF‐free survival was favored in the Vizigo group (91.8% vs. 83.3%; p = 0.203).
Conclusions
Using a 3D‐EAM visualized steerable sheath significantly reduced fluoroscopy time without prolonging the AF ablation procedure, making a zero‐fluoroscopy ablation strategy feasible after transseptal puncture. Furthermore, the improved left‐sided first‐pass PVI success observed with the Vizigo sheath may have implications for procedural efficacy, although its effect on long‐term outcomes warrants further investigation with larger cohorts.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.
ORCID profiles: Chun-Kai Chen, Chih-Chieh Yu, Yen-Bin Liu
Funding
- Johnson & Johnson
- Johnson and Johnson
Cite
APA
Chen, C. K., Yu, C. C., Liao, M. T., Huang, H. C., & Liu, Y. B. (2026). The Impact of a Visualized Steerable Sheath on Radiofrequency Catheter Ablation for First‐Time Atrial Fibrillation Ablation: A Prospective, Randomized, Single‐Blind Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70716
Vancouver
Chen CK, Yu CC, Liao MT, Huang HC, Liu YB. The Impact of a Visualized Steerable Sheath on Radiofrequency Catheter Ablation for First‐Time Atrial Fibrillation Ablation: A Prospective, Randomized, Single‐Blind Study. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70716
BibTeX
@article{Chen2026,
author = {Chen, Chun-Kai and Yu, Chih-Chieh and Liao, Min-Tsun and Huang, Hui-Chun and Liu, Yen-Bin},
title = {The Impact of a Visualized Steerable Sheath on Radiofrequency Catheter Ablation for First‐Time Atrial Fibrillation Ablation: A Prospective, Randomized, Single‐Blind Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70716}
}
EUVIMED